Global Peptide CRDMO Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market by Type
  • 1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
  • 1.2.2 Solid-Phase Peptide Synthesis
  • 1.2.3 Liquid-Phase Peptide Synthesis
• 1.3 Market by Application
  • 1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Pharmaceuticals
  • 1.3.3 Scientific Research
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Peptide CRDMO Market Perspective (2020-2031)
• 2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
• 2.3 Global Peptide CRDMO Revenue Market Share by Region (2020-2025)
• 2.4 Global Peptide CRDMO Revenue Forecast by Region (2026-2031)
• 2.5 Major Region and Emerging Market Analysis
  • 2.5.1 North America Peptide CRDMO Market Size and Prospective (2020-2031)
  • 2.5.2 Europe Peptide CRDMO Market Size and Prospective (2020-2031)
  • 2.5.3 China Peptide CRDMO Market Size and Prospective (2020-2031)
  • 2.5.4 Japan Peptide CRDMO Market Size and Prospective (2020-2031)
  • 2.5.5 Southeast Asia Peptide CRDMO Market Size and Prospective (2020-2031)
  • 2.5.6 India Peptide CRDMO Market Size and Prospective (2020-2031)
  • 2.5.7 South America Peptide CRDMO Market Size and Prospective (2020-2031)
  • 2.5.8 Middle East Peptide CRDMO Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

• 3.1 Global Peptide CRDMO Historic Market Size by Type (2020-2025)
• 3.2 Global Peptide CRDMO Forecasted Market Size by Type (2026-2031)
• 3.3 Different Types Peptide CRDMO Representative Players

4 Breakdown Data by Application

• 4.1 Global Peptide CRDMO Historic Market Size by Application (2020-2025)
• 4.2 Global Peptide CRDMO Forecasted Market Size by Application (2026-2031)
• 4.3 New Sources of Growth in Peptide CRDMO Application

5 Competition Landscape by Players

• 5.1 Global Top Players by Revenue
  • 5.1.1 Global Top Peptide CRDMO Players by Revenue (2020-2025)
  • 5.1.2 Global Peptide CRDMO Revenue Market Share by Players (2020-2025)
• 5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 5.3 Players Covered: Ranking by Peptide CRDMO Revenue
• 5.4 Global Peptide CRDMO Market Concentration Analysis
  • 5.4.1 Global Peptide CRDMO Market Concentration Ratio (CR5 and HHI)
  • 5.4.2 Global Top 10 and Top 5 Companies by Peptide CRDMO Revenue in 2024
• 5.5 Global Key Players of Peptide CRDMO Head office and Area Served
• 5.6 Global Key Players of Peptide CRDMO, Product and Application
• 5.7 Global Key Players of Peptide CRDMO, Date of Enter into This Industry
• 5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

• 6.1 North America Market: Players, Segments and Downstream
  • 6.1.1 North America Peptide CRDMO Revenue by Company (2020-2025)
  • 6.1.2 North America Market Size by Type
    • 6.1.2.1 North America Peptide CRDMO Market Size by Type (2020-2025)
    • 6.1.2.2 North America Peptide CRDMO Market Share by Type (2020-2025)
  • 6.1.3 North America Market Size by Application
    • 6.1.3.1 North America Peptide CRDMO Market Size by Application (2020-2025)
    • 6.1.3.2 North America Peptide CRDMO Market Share by Application (2020-2025)
  • 6.1.4 North America Market Trend and Opportunities
• 6.2 Europe Market: Players, Segments and Downstream
  • 6.2.1 Europe Peptide CRDMO Revenue by Company (2020-2025)
  • 6.2.2 Europe Market Size by Type
    • 6.2.2.1 Europe Peptide CRDMO Market Size by Type (2020-2025)
    • 6.2.2.2 Europe Peptide CRDMO Market Share by Type (2020-2025)
  • 6.2.3 Europe Market Size by Application
    • 6.2.3.1 Europe Peptide CRDMO Market Size by Application (2020-2025)
    • 6.2.3.2 Europe Peptide CRDMO Market Share by Application (2020-2025)
  • 6.2.4 Europe Market Trend and Opportunities
• 6.3 China Market: Players, Segments and Downstream
  • 6.3.1 China Peptide CRDMO Revenue by Company (2020-2025)
  • 6.3.2 China Market Size by Type
    • 6.3.2.1 China Peptide CRDMO Market Size by Type (2020-2025)
    • 6.3.2.2 China Peptide CRDMO Market Share by Type (2020-2025)
  • 6.3.3 China Market Size by Application
    • 6.3.3.1 China Peptide CRDMO Market Size by Application (2020-2025)
    • 6.3.3.2 China Peptide CRDMO Market Share by Application (2020-2025)
  • 6.3.4 China Market Trend and Opportunities
• 6.4 Japan Market: Players, Segments and Downstream
  • 6.4.1 Japan Peptide CRDMO Revenue by Company (2020-2025)
  • 6.4.2 Japan Market Size by Type
    • 6.4.2.1 Japan Peptide CRDMO Market Size by Type (2020-2025)
    • 6.4.2.2 Japan Peptide CRDMO Market Share by Type (2020-2025)
  • 6.4.3 Japan Market Size by Application
    • 6.4.3.1 Japan Peptide CRDMO Market Size by Application (2020-2025)
    • 6.4.3.2 Japan Peptide CRDMO Market Share by Application (2020-2025)
  • 6.4.4 Japan Market Trend and Opportunities
• 6.5 Southeast Asia Market: Players, Segments and Downstream
  • 6.5.1 Southeast Asia Peptide CRDMO Revenue by Company (2020-2025)
  • 6.5.2 Southeast Asia Market Size by Type
    • 6.5.2.1 Southeast Asia Peptide CRDMO Market Size by Type (2020-2025)
    • 6.5.2.2 Southeast Asia Peptide CRDMO Market Share by Type (2020-2025)
  • 6.5.3 Southeast Asia Market Size by Application
    • 6.5.3.1 Southeast Asia Peptide CRDMO Market Size by Application (2020-2025)
    • 6.5.3.2 Southeast Asia Peptide CRDMO Market Share by Application (2020-2025)
  • 6.5.4 Southeast Asia Market Trend and Opportunities
• 6.6 India Market: Players, Segments and Downstream
  • 6.6.1 India Peptide CRDMO Revenue by Company (2020-2025)
  • 6.6.2 India Market Size by Type
    • 6.6.2.1 India Peptide CRDMO Market Size by Type (2020-2025)
    • 6.6.2.2 India Peptide CRDMO Market Share by Type (2020-2025)
  • 6.6.3 India Market Size by Application
    • 6.6.3.1 India Peptide CRDMO Market Size by Application (2020-2025)
    • 6.6.3.2 India Peptide CRDMO Market Share by Application (2020-2025)
  • 6.6.4 India Market Trend and Opportunities

7 Key Players Profiles

• 7.1 Bachem
  • 7.1.1 Bachem Company Details
  • 7.1.2 Bachem Business Overview
  • 7.1.3 Bachem Peptide CRDMO Introduction
  • 7.1.4 Bachem Revenue in Peptide CRDMO Business (2020-2025)
  • 7.1.5 Bachem Recent Development
• 7.2 PolyPeptide
  • 7.2.1 PolyPeptide Company Details
  • 7.2.2 PolyPeptide Business Overview
  • 7.2.3 PolyPeptide Peptide CRDMO Introduction
  • 7.2.4 PolyPeptide Revenue in Peptide CRDMO Business (2020-2025)
  • 7.2.5 PolyPeptide Recent Development
• 7.3 Ambio
  • 7.3.1 Ambio Company Details
  • 7.3.2 Ambio Business Overview
  • 7.3.3 Ambio Peptide CRDMO Introduction
  • 7.3.4 Ambio Revenue in Peptide CRDMO Business (2020-2025)
  • 7.3.5 Ambio Recent Development
• 7.4 USV Peptide
  • 7.4.1 USV Peptide Company Details
  • 7.4.2 USV Peptide Business Overview
  • 7.4.3 USV Peptide Peptide CRDMO Introduction
  • 7.4.4 USV Peptide Revenue in Peptide CRDMO Business (2020-2025)
  • 7.4.5 USV Peptide Recent Development
• 7.5 BCNpeptides
  • 7.5.1 BCNpeptides Company Details
  • 7.5.2 BCNpeptides Business Overview
  • 7.5.3 BCNpeptides Peptide CRDMO Introduction
  • 7.5.4 BCNpeptides Revenue in Peptide CRDMO Business (2020-2025)
  • 7.5.5 BCNpeptides Recent Development
• 7.6 Lonza
  • 7.6.1 Lonza Company Details
  • 7.6.2 Lonza Business Overview
  • 7.6.3 Lonza Peptide CRDMO Introduction
  • 7.6.4 Lonza Revenue in Peptide CRDMO Business (2020-2025)
  • 7.6.5 Lonza Recent Development
• 7.7 CordenPharma
  • 7.7.1 CordenPharma Company Details
  • 7.7.2 CordenPharma Business Overview
  • 7.7.3 CordenPharma Peptide CRDMO Introduction
  • 7.7.4 CordenPharma Revenue in Peptide CRDMO Business (2020-2025)
  • 7.7.5 CordenPharma Recent Development
• 7.8 PeptiDream
  • 7.8.1 PeptiDream Company Details
  • 7.8.2 PeptiDream Business Overview
  • 7.8.3 PeptiDream Peptide CRDMO Introduction
  • 7.8.4 PeptiDream Revenue in Peptide CRDMO Business (2020-2025)
  • 7.8.5 PeptiDream Recent Development
• 7.9 AmbioPharm
  • 7.9.1 AmbioPharm Company Details
  • 7.9.2 AmbioPharm Business Overview
  • 7.9.3 AmbioPharm Peptide CRDMO Introduction
  • 7.9.4 AmbioPharm Revenue in Peptide CRDMO Business (2020-2025)
  • 7.9.5 AmbioPharm Recent Development
• 7.10 CPC Scientific
  • 7.10.1 CPC Scientific Company Details
  • 7.10.2 CPC Scientific Business Overview
  • 7.10.3 CPC Scientific Peptide CRDMO Introduction
  • 7.10.4 CPC Scientific Revenue in Peptide CRDMO Business (2020-2025)
  • 7.10.5 CPC Scientific Recent Development
• 7.11 Sinopep
  • 7.11.1 Sinopep Company Details
  • 7.11.2 Sinopep Business Overview
  • 7.11.3 Sinopep Peptide CRDMO Introduction
  • 7.11.4 Sinopep Revenue in Peptide CRDMO Business (2020-2025)
  • 7.11.5 Sinopep Recent Development
• 7.12 SynZeal
  • 7.12.1 SynZeal Company Details
  • 7.12.2 SynZeal Business Overview
  • 7.12.3 SynZeal Peptide CRDMO Introduction
  • 7.12.4 SynZeal Revenue in Peptide CRDMO Business (2020-2025)
  • 7.12.5 SynZeal Recent Development
• 7.13 Cambrex Corporation
  • 7.13.1 Cambrex Corporation Company Details
  • 7.13.2 Cambrex Corporation Business Overview
  • 7.13.3 Cambrex Corporation Peptide CRDMO Introduction
  • 7.13.4 Cambrex Corporation Revenue in Peptide CRDMO Business (2020-2025)
  • 7.13.5 Cambrex Corporation Recent Development
• 7.14 Tide Pharmaceutical
  • 7.14.1 Tide Pharmaceutical Company Details
  • 7.14.2 Tide Pharmaceutical Business Overview
  • 7.14.3 Tide Pharmaceutical Peptide CRDMO Introduction
  • 7.14.4 Tide Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025)
  • 7.14.5 Tide Pharmaceutical Recent Development
• 7.15 Hybio Pharmaceutical
  • 7.15.1 Hybio Pharmaceutical Company Details
  • 7.15.2 Hybio Pharmaceutical Business Overview
  • 7.15.3 Hybio Pharmaceutical Peptide CRDMO Introduction
  • 7.15.4 Hybio Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025)
  • 7.15.5 Hybio Pharmaceutical Recent Development
• 7.16 Rochi Pharma
  • 7.16.1 Rochi Pharma Company Details
  • 7.16.2 Rochi Pharma Business Overview
  • 7.16.3 Rochi Pharma Peptide CRDMO Introduction
  • 7.16.4 Rochi Pharma Revenue in Peptide CRDMO Business (2020-2025)
  • 7.16.5 Rochi Pharma Recent Development

8 Peptide CRDMO Market Dynamics

• 8.1 Peptide CRDMO Industry Trends
• 8.2 Peptide CRDMO Market Drivers
• 8.3 Peptide CRDMO Market Challenges
• 8.4 Peptide CRDMO Market Restraints

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer

List of Tables

Table 1. Global Peptide CRDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Peptide CRDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Peptide CRDMO Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Peptide CRDMO Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Peptide CRDMO Revenue Share by Region (2020-2025)

Table 6. Global Peptide CRDMO Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Peptide CRDMO Revenue Share Forecast by Region (2026-2031)

Table 8. Global Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Peptide CRDMO Revenue Market Share by Type (2020-2025)

Table 10. Global Peptide CRDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Peptide CRDMO Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Peptide CRDMO Revenue Market Share by Application (2020-2025)

Table 15. Global Peptide CRDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Peptide CRDMO Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Peptide CRDMO Application

Table 18. Global Peptide CRDMO Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Peptide CRDMO Market Share by Players (2020-2025)

Table 20. Global Top Peptide CRDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CRDMO as of 2024)

Table 21. Ranking of Global Top Peptide CRDMO Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Peptide CRDMO Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Peptide CRDMO, Headquarters and Area Served

Table 24. Global Key Players of Peptide CRDMO, Product and Application

Table 25. Global Key Players of Peptide CRDMO, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 29. North America Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 33. Europe Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 37. China Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 41. Japan Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 43. Southeast Asia Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 44. Southeast Asia Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 45. Southeast Asia Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 46. Southeast Asia Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 47. India Peptide CRDMO Revenue by Company (2020-2025) & (US$ Million)

Table 48. India Peptide CRDMO Revenue Market Share by Company (2020-2025)

Table 49. India Peptide CRDMO Market Size by Type (2020-2025) & (US$ Million)

Table 50. India Peptide CRDMO Market Size by Application (2020-2025) & (US$ Million)

Table 51. Bachem Company Details

Table 52. Bachem Business Overview

Table 53. Bachem Peptide CRDMO Product

Table 54. Bachem Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 55. Bachem Recent Development

Table 56. PolyPeptide Company Details

Table 57. PolyPeptide Business Overview

Table 58. PolyPeptide Peptide CRDMO Product

Table 59. PolyPeptide Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 60. PolyPeptide Recent Development

Table 61. Ambio Company Details

Table 62. Ambio Business Overview

Table 63. Ambio Peptide CRDMO Product

Table 64. Ambio Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 65. Ambio Recent Development

Table 66. USV Peptide Company Details

Table 67. USV Peptide Business Overview

Table 68. USV Peptide Peptide CRDMO Product

Table 69. USV Peptide Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 70. USV Peptide Recent Development

Table 71. BCNpeptides Company Details

Table 72. BCNpeptides Business Overview

Table 73. BCNpeptides Peptide CRDMO Product

Table 74. BCNpeptides Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 75. BCNpeptides Recent Development

Table 76. Lonza Company Details

Table 77. Lonza Business Overview

Table 78. Lonza Peptide CRDMO Product

Table 79. Lonza Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 80. Lonza Recent Development

Table 81. CordenPharma Company Details

Table 82. CordenPharma Business Overview

Table 83. CordenPharma Peptide CRDMO Product

Table 84. CordenPharma Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 85. CordenPharma Recent Development

Table 86. PeptiDream Company Details

Table 87. PeptiDream Business Overview

Table 88. PeptiDream Peptide CRDMO Product

Table 89. PeptiDream Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 90. PeptiDream Recent Development

Table 91. AmbioPharm Company Details

Table 92. AmbioPharm Business Overview

Table 93. AmbioPharm Peptide CRDMO Product

Table 94. AmbioPharm Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 95. AmbioPharm Recent Development

Table 96. CPC Scientific Company Details

Table 97. CPC Scientific Business Overview

Table 98. CPC Scientific Peptide CRDMO Product

Table 99. CPC Scientific Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 100. CPC Scientific Recent Development

Table 101. Sinopep Company Details

Table 102. Sinopep Business Overview

Table 103. Sinopep Peptide CRDMO Product

Table 104. Sinopep Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 105. Sinopep Recent Development

Table 106. SynZeal Company Details

Table 107. SynZeal Business Overview

Table 108. SynZeal Peptide CRDMO Product

Table 109. SynZeal Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 110. SynZeal Recent Development

Table 111. Cambrex Corporation Company Details

Table 112. Cambrex Corporation Business Overview

Table 113. Cambrex Corporation Peptide CRDMO Product

Table 114. Cambrex Corporation Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 115. Cambrex Corporation Recent Development

Table 116. Tide Pharmaceutical Company Details

Table 117. Tide Pharmaceutical Business Overview

Table 118. Tide Pharmaceutical Peptide CRDMO Product

Table 119. Tide Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 120. Tide Pharmaceutical Recent Development

Table 121. Hybio Pharmaceutical Company Details

Table 122. Hybio Pharmaceutical Business Overview

Table 123. Hybio Pharmaceutical Peptide CRDMO Product

Table 124. Hybio Pharmaceutical Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 125. Hybio Pharmaceutical Recent Development

Table 126. Rochi Pharma Company Details

Table 127. Rochi Pharma Business Overview

Table 128. Rochi Pharma Peptide CRDMO Product

Table 129. Rochi Pharma Revenue in Peptide CRDMO Business (2020-2025) & (US$ Million)

Table 130. Rochi Pharma Recent Development

Table 131. Peptide CRDMO Market Trends

Table 132. Peptide CRDMO Market Drivers

Table 133. Peptide CRDMO Market Challenges

Table 134. Peptide CRDMO Market Restraints

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

List of Figures

Figure 1. Peptide CRDMO Product Picture

Figure 2. Global Peptide CRDMO Market Share by Type: 2024 VS 2031

Figure 3. Solid-Phase Peptide Synthesis Features

Figure 4. Liquid-Phase Peptide Synthesis Features

Figure 5. Global Peptide CRDMO Market Share by Application: 2024 VS 2031

Figure 6. Pharmaceuticals

Figure 7. Scientific Research

Figure 8. Others

Figure 9. Peptide CRDMO Report Years Considered

Figure 10. Global Peptide CRDMO Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 11. Global Peptide CRDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Peptide CRDMO Revenue Market Share by Region: 2020 VS 2024

Figure 13. North America Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 14. Europe Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 15. China Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. Japan Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Southeast Asia Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. India Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. South America Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Middle East Peptide CRDMO Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Global Peptide CRDMO Market Share by Players in 2024

Figure 22. Global Top Peptide CRDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CRDMO as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Peptide CRDMO Revenue in 2024

Figure 24. North America Peptide CRDMO Market Share by Type (2020-2025)

Figure 25. North America Peptide CRDMO Market Share by Application (2020-2025)

Figure 26. Europe Peptide CRDMO Market Share by Type (2020-2025)

Figure 27. Europe Peptide CRDMO Market Share by Application (2020-2025)

Figure 28. China Peptide CRDMO Market Share by Type (2020-2025)

Figure 29. China Peptide CRDMO Market Share by Application (2020-2025)

Figure 30. Japan Peptide CRDMO Market Share by Type (2020-2025)

Figure 31. Japan Peptide CRDMO Market Share by Application (2020-2025)

Figure 32. Southeast Asia Peptide CRDMO Market Share by Type (2020-2025)

Figure 33. Southeast Asia Peptide CRDMO Market Share by Application (2020-2025)

Figure 34. India Peptide CRDMO Market Share by Type (2020-2025)

Figure 35. India Peptide CRDMO Market Share by Application (2020-2025)

Figure 36. Bachem Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 37. PolyPeptide Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 38. Ambio Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 39. USV Peptide Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 40. BCNpeptides Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 41. Lonza Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 42. CordenPharma Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 43. PeptiDream Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 44. AmbioPharm Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 45. CPC Scientific Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 46. Sinopep Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 47. SynZeal Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 48. Cambrex Corporation Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 49. Tide Pharmaceutical Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 50. Hybio Pharmaceutical Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 51. Rochi Pharma Revenue Growth Rate in Peptide CRDMO Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed